These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11454125)

  • 1. Urinary incontinence management: new questions from old assumptions.
    DuBeau CE
    J Am Geriatr Soc; 2001 Jun; 49(6):829-30. PubMed ID: 11454125
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity--a comment.
    Short DD
    Pharmacotherapy; 1999 Oct; 19(10):1188. PubMed ID: 10512072
    [No Abstract]   [Full Text] [Related]  

  • 3. Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine.
    Kobelt G; Kirchberger I; Malone-Lee J
    BJU Int; 1999 Apr; 83(6):583-90. PubMed ID: 10233562
    [No Abstract]   [Full Text] [Related]  

  • 4. Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
    Rovner ES; Wein AJ
    BJU Int; 2000 Oct; 86 Suppl 2():44-53; discussion 53-4. PubMed ID: 11501617
    [No Abstract]   [Full Text] [Related]  

  • 5. Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
    Staskin DR; Dmochowski RR; Wein AJ
    Curr Urol Rep; 2005 Nov; 6(6):403-4. PubMed ID: 16238911
    [No Abstract]   [Full Text] [Related]  

  • 6. Hallucinations with tolterodine.
    Williams SG; Staudenmeier J
    Psychiatr Serv; 2004 Nov; 55(11):1318-9. PubMed ID: 15534031
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed incontinence.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2055-7. PubMed ID: 15879826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of mixed urinary incontinence].
    Goepel M
    Urologe A; 2003 Jun; 42(6):812-7. PubMed ID: 12851773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A meta-analysis documenting the optimal tolerance profile of tolterodine].
    Rev Med Suisse; 2006 May; 2(65):1234. PubMed ID: 16767876
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolterodine for the treatment of daytime incontinence in children.
    Greenfield SP
    J Urol; 2005 Apr; 173(4):1064. PubMed ID: 15758701
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolterodine.
    Nurs Times; 2006 Jun 6-12; 102(23):27. PubMed ID: 16784047
    [No Abstract]   [Full Text] [Related]  

  • 12. PHARMAC responds on tolterodine for overactive bladder.
    Moodie P
    N Z Med J; 2005 Feb; 119(1229):U1871. PubMed ID: 16498471
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolterodine for the treatment of overactive bladder: a review.
    Rovner ES
    Expert Opin Pharmacother; 2005 Apr; 6(4):653-66. PubMed ID: 15934891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Athanasopoulos AA; Perimenis PS
    BJU Int; 2005 May; 95(7):1117-8. PubMed ID: 15839945
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolterodine: a safe and effective treatment for older patients with overactive bladder.
    Kausar SA
    J Am Geriatr Soc; 2002 Apr; 50(4):775. PubMed ID: 11982685
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolterodine.
    Hills CJ; Winter SA; Balfour JA
    Drugs; 1998 Jun; 55(6):813-20; discussion 821-2. PubMed ID: 9617596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolterodine: a safe and effective treatment for older patients with overactive bladder.
    Malone-Lee JG; Walsh JB; Maugourd MF
    J Am Geriatr Soc; 2001 Jun; 49(6):700-5. PubMed ID: 11454106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis.
    Harvey MA; Baker K; Wells GA
    Am J Obstet Gynecol; 2001 Jul; 185(1):56-61. PubMed ID: 11483904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.
    Roberts RG; Garely AD; Bavendam T
    Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.